ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2204

Overall Agreement Between Sjögrens’s Minor Salivary Gland Biopsy and 2002 and 2012 Classification Criteria

Laura Aline Martinez1, Candido Flores2, Alberto Arana Fraustro3 and Luis H. Silveira4, 1Rheumatology, Instituto Nacional de Cardiologia Ignacion Chavez, Mexico City, Mexico, 2Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, 3Pathology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, 4Rheumatology, Instituto Nacional Cardiología Ignacio Chávez, Mexico City, Mexico

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome and classification criteria

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Sjögren's Syndrome - Clinical

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Sjögren’s syndrome (SS) is an inflammatory autoimmune disease characterized by lymphoid infiltration of exocrine glands, although extraglandular involvement is frequently observed. Prevalence is around 0.5% to 1%. There have always been difficulties for the classification and diagnosis of patients. Several criteria have been proposed. The classification criteria used in recent years where those established by the American-European Consensus Group in 2002. Recently, new classification criteria have been published by the International Collaborative Clinical Alliance Cohort; these criteria have been approved by the American College of Rheumatology. Although minor salivary gland biopsy has been used throughout the years, its findings are not highly specific.

Objectives:  Primary. To determine the agreement between a positive minor salivary gland biopsy and having al least 4 of the 6, 2002 criteria, as well as having 2 of the 3, 2012 criteria. Secondary: To determine the agreement between 2002 and 2012 SS classification criteria.

Methods:

This is a retrospective study consisting of clinical chart review from patients with primary SS (PSS) and secondary SS (SSS), having minor salivary gland biopsy report.  Clinical chart review included patients attending the Rheumatology Clinic at the National Institute of Cardiology in Mexico City, between January 1, 2000, and May 31, 2011. Clinical manifestations, serology, and the biopsy report were obtained in all patients. Biopsies were considered positive when a focal lymphocytic sialadenitis with a focus score ≥ 1 focus (> 50 cells)/4 mm2 was observed. Biopsies were assessed by the same expert pathologist. The 2002 and 2012 criteria were applied according to their requirements. Descriptive statistic was used and kappa index was calculated as an agreement measure. A p value < 0.05 was considered  significant.  SPSS version 15.0 was used for the statistical analysis.

Results:

A total of 75 clinical charts with a biopsy report were reviewed; 8 patients were excluded because information was incomplete. 67 patients were included in the analysis, 62 women and 5 men.  55.2% had PSS and 44.8% had SSS.  The agreement between a positive biopsy and having 4 of the 6, 2002 criteria, was weak (kappa = 0.27; p = 0.01); the agreement of a positive biopsy with having 2 of the 3, 2012 criteria, was moderate (kappa = 0.5; p < 0.0001).  The agreement between the 2002 criteria and the 2012 criteria was good (kappa = 0.70; p < 0.0001), when all the patients were considered. In the SSS patients, the agreement decreased (kappa = 0.44; p = 0.003).

Conclusion:

The agreement between a positive biopsy and having 4 of the 2002 criteria was low, and moderate when having 2 of the 20012 criteria.  The agreement between the 2002 and the 2012 criteria was very good when PSS patients were included, however, it decreased when only the SSS patients were included.


Disclosure:

L. A. Martinez,
None;

C. Flores,
None;

A. Arana Fraustro,
None;

L. H. Silveira,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/overall-agreement-between-sjogrenss-minor-salivary-gland-biopsy-and-2002-and-2012-classification-criteria/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology